Health
The Lundquist Institute out-licenses development of a synthetic lung surfactant formulation – EurekAlert
TLI-Gates MRI agreement advances evolution of synthetic lung surfactants to treat respiratory distress syndrome in premature infants in low- and middle-income countries….
-AGREEMENT ADVANCES EVOLUTION OF SYNTHETIC LUNG SURFACTANTS TO TREAT RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS IN LOW- AND MIDDLE-INCOME COUNTRIES-
LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant formulation to be developed for respiratory distress syndrome (RDS) for premature infants in Low- and Middle-Income countries…
-
General19 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
Noosa News18 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General21 hours agoBack-to-back rate cuts tipped when Reserve Bank meets